View printer-friendly version

Download PDF

Emergent BioSolutions to Participate in October 2010 Investor Conferences

ROCKVILLE, Md., Sep 27, 2010 (BUSINESS WIRE) —

Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company will be participating in the following investor conferences in October 2010.

• The 9^th Annual BIO Investor Forum
  San Francisco, CA.
  October 5, 2010
  Corporate Overview Presentation
  9:00 AM Pacific
  [The presentation, which will include a discussion of the Company’s business activities, financial outlook and current news, will be webcast live.]

• The 17^th Annual BioCentury/Thomson Reuters Newsmakers in the Biotech Industry Conference
  New York, NY.
  October 22, 2010
  Corporate Overview Presentation
  2:00 PM Eastern
  [The presentation, which will include a discussion of the Company’s business activities, financial outlook and current news, will be webcast live.]

Both webcasts will be accessible from the Emergent website www.emergentbiosolutions.com under “Investors”.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax^(R) (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent’s product pipeline targets infectious diseases and includes programs focused on anthrax, tuberculosis, typhoid, flu and chlamydia. Additional information may be found at www.emergentbiosolutions.com.

SOURCE: Emergent BioSolutions Inc.